Precision BioSciences Inc (DTIL)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $288.76M
Last updated: Nov 17, 2026 at 11:04 AM ET
Precision BioSciences Inc (DTIL) Competitors
The companies most similar to Precision BioSciences are Editas Medicine (EDIT), SAB Biotherapeutics (SABS) and Palisade Bio (PALI). By market cap, Precision BioSciences ranks 6th of the 13 companies on this page; Prothena Corporation (PRTA) is the largest at $419.01M.
Peer Comparison
DTIL's ROIC of -38.3% is above the peer median of -42.3%, and its revenue growth of 37272.0% is above the median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Precision BioSciences (DTIL) | $288.76M | N/A | 4.4x | -85.6% | -38.3% | 37272.0% | 0.00% |
| Editas Medicine Inc (EDIT) | $334.92M | N/A | 5.6x | -145.0% | -42.3% | 37.4% | 0.00% |
| SAB Biotherapeutics Inc (SABS) | $266.66M | N/A | N/A | 0.0% | N/A | -62.4% | 0.00% |
| Palisade Bio Inc (PALI) | $201.01M | N/A | 436.8x | 0.0% | N/A | 0.0% | 0.00% |
| PepGen Ltd (PEPG) | $410.98M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Puma Biotechnology Inc (PBYI) | $401.70M | 15.0x | 1.6x | 10.3% | N/A | 1.1% | 0.00% |
| Nautilus Biotechnology Inc (NAUT) | $295.50M | N/A | 630.2x | 0.0% | N/A | 0.0% | 0.00% |
| Prelude Therapeutics Inc (PRLD) | $275.32M | N/A | 16.3x | -269.7% | N/A | 41.0% | 0.00% |
| Korro Bio, Inc. (KRRO) | $186.81M | N/A | 175.8x | 0.0% | -82.8% | -43.1% | 0.00% |
| Rocket Pharmaceuticals Inc (RCKT) | $256.82M | N/A | N/A | 0.0% | -2.3% | 0.0% | 0.00% |
| ProQR Therapeutics BV (PRQR) | $199.28M | N/A | 6.1x | -228.2% | N/A | 120.4% | 0.00% |
| Protalix Biotherapeutics Inc (PLX) | $257.17M | 12.1x | 2.9x | 24.3% | N/A | 22.8% | 0.00% |
| Prothena Corporation plc (PRTA) | $419.01M | N/A | 7.8x | -45.4% | N/A | -74.3% | 0.00% |
| Peer median | $270.99M | 13.5x | 7.8x | 0.0% | -42.3% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Precision BioSciences, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Editas Medicine Inc (EDIT) | Editas Medicine, Inc., a clinical-stage genome editing company, is focused on developing transformative genomic drugs to treat a variety of serious diseases. | EDIT competitors |
| SAB Biotherapeutics Inc (SABS) | SAB Biotherapeutics, Inc., a biopharmaceutical company, develops immunotherapies against infectious diseases, autoimmune diseases, and oncology. | SABS competitors |
| Palisade Bio Inc (PALI) | Leading BioSciences, Inc. develops therapies to improve human health through therapeutic protection of the gastrointestinal mucosal barrier. | PALI competitors |
| PepGen Ltd (PEPG) | PepGen Inc., a clinical-stage biotechnology company, is focused on the development of oligonucleotide therapeutics for use in the treatment of serious... | PEPG competitors |
| Puma Biotechnology Inc (PBYI) | Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to improve cancer care in the United States... | PBYI competitors |
| Nautilus Biotechnology Inc (NAUT) | Nautilus Biotechnology, Inc., a development-stage life sciences company, is dedicated to creating platform technology to quantify and unlock proteome... | NAUT competitors |
| Prelude Therapeutics Inc (PRLD) | Prelude Therapeutics Incorporated, a precision clinical-stage oncology company, focuses on the discovery and development of small molecule therapies optimized... | PRLD competitors |
| Korro Bio, Inc. (KRRO) | Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare... | KRRO competitors |
| Rocket Pharmaceuticals Inc (RCKT) | Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases. | RCKT competitors |
| ProQR Therapeutics BV (PRQR) | ProQR Therapeutics NV, a biopharmaceutical company, is dedicated to the discovery and development of RNA-based therapies for the treatment of genetic disorders. | PRQR competitors |
| Protalix Biotherapeutics Inc (PLX) | Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its... | PLX competitors |
| Prothena Corporation plc (PRTA) | Prothena Corporation plc, an advanced stage clinical company, is focused on the discovery and development of new therapies for life-threatening diseases... | PRTA competitors |
Frequently Asked Questions About DTIL
Who are Precision BioSciences' main competitors?
The companies most similar to Precision BioSciences include Editas Medicine (EDIT), SAB Biotherapeutics (SABS), Palisade Bio (PALI), PepGen (PEPG) and Puma Biotechnology (PBYI), listed from the closest match.
Who is Precision BioSciences' biggest competitor?
Prothena Corporation (PRTA) is the largest of the similar companies at $419.01M; Editas Medicine (EDIT) is the closest match by business profile, size, sector and industry.
How does DTIL stock compare with its competitors?
DTIL's P/S is 4.4x against a peer median of 7.8x; its net margin is -85.6% against a peer median of 0.0%.
Which of Precision BioSciences' competitors pays a higher dividend?
Precision BioSciences pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Precision BioSciences bigger than its competitors?
No. Precision BioSciences is 6th by market cap among the 13 companies on this page; the largest is Prothena Corporation (PRTA) at $419.01M.
DTIL pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors